Skip to main content

Pediculosis

5
Pipeline Programs
3
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
1
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

ParaPRO
ParaPROIN - Carmel
2 programs
1
1
spinosadPhase 41 trial
SpinosadPhase 31 trial
Active Trials
NCT00545753Completed558Est. May 2008
NCT01660321Completed26Est. Mar 2012
Dr. Reddy's Laboratories
2 programs
1
1
Group A - Low-Dose Ha44 0.37% w/wPhase 21 trial
Ha44Phase 11 trial
Active Trials
NCT01518699Completed57Est. May 2012
NCT01336647Completed142Est. Mar 2012
Combined Therapeutics
1 program
1
Permethrin 5% topical lotionPhase 11 trial
Active Trials
NCT05643820Completed60Est. Aug 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ParaPROspinosad
ParaPROSpinosad
Dr. Reddy's LaboratoriesGroup A - Low-Dose Ha44 0.37% w/w
Combined TherapeuticsPermethrin 5% topical lotion
Dr. Reddy's LaboratoriesHa44

Clinical Trials (5)

Total enrollment: 843 patients across 5 trials

NCT01660321ParaPROspinosad

Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation

Start: Sep 2011Est. completion: Mar 201226 patients
Phase 4Completed
NCT00545753ParaPROSpinosad

Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice

Start: Sep 2007Est. completion: May 2008558 patients
Phase 3Completed
NCT01336647Dr. Reddy's LaboratoriesGroup A - Low-Dose Ha44 0.37% w/w

An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation

Start: Apr 2011Est. completion: Mar 2012142 patients
Phase 2Completed
NCT05643820Combined TherapeuticsPermethrin 5% topical lotion

Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis

Start: Mar 2022Est. completion: Aug 202260 patients
Phase 1Completed
NCT01518699Dr. Reddy's LaboratoriesHa44

Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers

Start: Jan 2012Est. completion: May 201257 patients
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.